Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases. Cardiovascular implants are made up of different materials such as metals and its alloys, polymers, and biological materials. There are various cardiovascular implants such as CRTs, ICDs, ICPs, coronary stents, peripheral stents, and heart valves.
Technavio's analysts forecast the global cardiovascular implants market to grow at a CAGR of 4.54% over the period 2014-2019.
Covered in this report
This report covers the present and future scenario of the global cardiovascular implants market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of cardiovascular implants.Technavio's report, Global Cardiovascular Implants Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
St. Jude Medical
Other prominent vendors
On-X Life Technologies
W.L. Gore & Associates
Growing incidence of cardiovascular disorders
For a full, detailed list, view our reportMarket challenge
For a full, detailed list, view our reportMarket trend
Growing popularity of robotic assistance surgeries
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Technavio Announces the Publication of its Research Report – Global Cardiovascular Implants Market 2015-2019 Technavio recognizes the following companies as the key players in the Global Cardiovascular Implants Market: Abbott Laboratories, Boston Scientific, Medtronic and St. Jude Medical Other Prominent Vendors in the market are: AMG International, Biotronik, B-Braun, Cardiac Dimension, Cardiac Science, Edwards Lifesciences, Fortimedix, Neovasc, On-X Life Technologies, Pacetronix, Proxy Biomedical, Reva Medical, Sorin and W.L. Gore & Associates Commenting on the report, an analyst from Technavio’s team said: “Advances in technology have led to the development of more accurate cardiovascular implant surgeries that provide better support to patients and surgeons. Vendors and research organizations are exploring different options to use intravascular robotics in a broad range of peripheral vascular procedures. Robotics provides surgeons a better view of the operative field and the ability to maneuver instruments within close-fitting spaces with precision and control. The technology has significantly helped improve the navigation of needles, catheters, and electrode tips to specific targets during surgeries. These procedures help to reduce hospital stays and facilitate cost management. Moreover, these procedures shorten the recovery period and lessen discomfort and pain. Aware of the benefits of robot-assisted surgeries, many hospitals will install and implement such equipment during the forecast period. Already, physicians in different universities, such as the University of Chicago and the University of Pennsylvania School of Medicine, US, are using robotic-assisted surgeries for research purposes.” According to the report, medical companies are developing many innovative cardiovascular implants to increase their revenue share. For instance, Medtronic has developed leadless pacemakers, bioabsorbable coronary scaffoldings, the CoreValve Evolut transcatheter aortic valve, and Engager transapical aortic valve. Most of these technologies are available in the US, and other developed countries such as Germany, Japan, the UK, and France. The development and introduction of innovative cardiovascular implants in the market will likely change treatment options in hospitals and increase the volume of those undergoing implantation surgeries. Further, the report states that the implantation procedures for cardiovascular devices are expensive.
Abbott Laboratories, Boston Scientific, Medtronic, St. Jude Medical, AMG International, Biotronik, B-Braun, Cardiac Dimension, Cardiac Science, Edwards Lifesciences, Fortimedix, Neovasc, On-X Life Technologies, Pacetronix, Proxy Biomedical, Reva Medical, Sorin, W.L. Gore & Associates